PetMeds reported a quarterly net loss of $6.4 million and decreased sales of 19.4% due to a decline in prescription medication sales and higher consumer promotional usage. These operational changes in the core direct-to-consumer pharmacy business indicate a continued shift in the company's profitability despite management's stated focus on stabilizing operations.